FEMALE ANDROGENETIC ALOPECIA

Clinical trials for FEMALE ANDROGENETIC ALOPECIA explained in plain language.

Never miss a new study

Get alerted when new FEMALE ANDROGENETIC ALOPECIA trials appear

Sign up with your email to follow new studies for FEMALE ANDROGENETIC ALOPECIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New pill aims to reverse hair loss in women

Disease control Recruiting now

This study is testing an investigational oral pill called VDPHL01 for women with genetic hair loss (female pattern baldness). It's a large, late-stage trial comparing the drug to a placebo to see if it safely increases hair count and improves appearance. The study lasts about 13 …

Matched conditions: FEMALE ANDROGENETIC ALOPECIA

Phase: PHASE3 • Sponsor: Veradermics, Inc. • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC

FEMALE ANDROGENETIC ALOPECIA

Get alerted when new FEMALE ANDROGENETIC ALOPECIA trials appear

New pill aims to reverse hair loss in women